The heterogenous nature of biopharmaceuticals makes them sensitive to subtle changes during manufacturing, processing and storage, that can impact their safety and efficacy in clinical use.
Understanding, defining and controlling such product variability is therefore a central challenge for all biopharmaceutical manufacturers to ensure batch-to-batch consistency.
Download this Article to learn more about:
- The impact of batch variability
- The importance of reproducibility during bioprocessing
- How equipment can be used to optimize reproducibility and batch consistency
